TFPR1 is a novel peptide vaccine adjuvant we recently discovered. To define the structural basis and optimize its application as an adjuvant, we designed three different truncated fragments that have removed dominant B epitopes on TFPR1, and evaluated their capacity to activate bone marrow-derived dendritic cells and their adjuvanticity. Results demonstrated that the integrity of an α-β-α sandwich conformation is essential for TFPR1 to maintain its immunologic activity and adjuvanticity. We obtained a functional truncated fragment TFPR-ta ranging from 40-168 aa of triflin that has similar adjuvanticity as TFPR1 but with 2-log fold lower immunogenicity. These results demonstrated a novel approach to evaluate and improve the activity of protein-based vaccine adjuvant.CAP signature motifs, just as the other members in the CAP superfamily [24]. Our previous studies indicated that recombinant protein TFPR1 augmented the immunogenicity of protein (OVA and recombinant HBsAg) and peptide (HIV-1 pep5 envelope) antigens, and induced Th1-biased antibodyand cell-mediated immune responses. Its adjuvant activity may be related to its capacity of activating antigen-processing cells, such as dendritic cells [25], B cells and macrophages, and promoting the secretion of Th1-biased proinflammatory and immunoregulatory cytokines [26]. However, as a protein adjuvant, TFPR1 has relatively strong immunogenicity [27], the structural basis of its function is not yet defined.In this study, we not only confirmed that TFPR1 acts as an effective adjuvant for peptide antigen, but also identified its minimal functional region. By rationally design functional fragment with minimum immunogenicity, through deleting B cell dominant epitopes while retaining its main structure and motifs, and expressed these truncated forms in E.coli protein expression system, we obtained a functional truncated fragment TFPR-ta ranging from 40-168 aa of triflin that has similar adjuvanticity as TFPR1 but with 2-log fold lower immunogenicity. Our results suggest that the integrity of the typical α-β-α sandwich conformational structure is essential for TFPR1 protein to maintain its adjuvanticity, and α1-helix and β4-fold cannot be deleted at the same time.